Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Protein Signatures Of Organ Aging Could Aid Disease Prevention Efforts

    Jan 23, 2024, 01:00 AM by User Not Found
    Bio-IT World | Stanford Medicine investigators are leading the development of a test measuring organ-specific proteins in the blood as a simple and sensible way to estimate biological age. Among the potential applications are screening people for conditions such as heart failure and Alzheimer’s disease, personalizing the intervention they’re prescribed, and signaling sooner the efficacy of investigational drugs based on how well they rejuvenate certain organs.
    Full story
  • Creative Biostructure Expands Liposome Offerings for Nucleic Acid Delivery

    Jan 22, 2024, 08:54 AM by
    Full story
  • CD BioGlyco Introduces New Polysaccharide Analysis Service to Accelerate Glycobiology Research

    Jan 22, 2024, 08:54 AM by
    Full story
  • PGA Identifies Effective Drugs for Non-responder Cancer Patients

    Jan 22, 2024, 08:54 AM by
    A breakthrough technology PGA brings gene-to-drug revolution in life.
    Full story
  • To Fight Superbugs, Ace Infectious Unveils Phage Therapy Development Services

    Jan 19, 2024, 09:05 AM by
    Full story
  • AES Clean Technology expands senior leadership team with key appointment

    Jan 19, 2024, 09:05 AM by
    Montgomeryville, Pennsylvania, January 18, 2024: A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO).
    Full story
  • Microbialtec: Your One-Stop Solution for Bacillus Genome Editing Needs

    Jan 19, 2024, 09:05 AM by
    Full story
  • Creative Biogene Offers High-Quality Biological Fermentation Services to Cater Research and Industrial Needs

    Jan 19, 2024, 09:05 AM by
    Full story
  • 1upHealth Commits to Supporting Health Plan Compliance with Latest CMS Interoperability Rule

    Jan 19, 2024, 09:05 AM by
    Full story
  • Inceptua Group and Cycle Pharmaceuticals Partner for a Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU)

    Jan 19, 2024, 09:05 AM by
    Inceptua Group and Cycle Pharmaceuticals Ltd have announced a partnership to make NITYR® Tablets available via a Free Goods Programme for eligible patients with Hereditary Tyrosinemia Type 1 and Alkaptonuria.
    Full story
  • Onyx Scientific Targets Stateside Expansion with New Appointment

    Jan 19, 2024, 09:05 AM by
    Onyx Scientific plans to drive forward its latest US expansion plans with the appointment of Anthony Harbour as Business Development Manager in North America
    Full story
  • Kalderos Names Two Industry Veterans to Executive Leadership Roles

    Jan 18, 2024, 08:49 AM by
    Kalderos Names Two Industry Veterans to Executive Leadership Roles
    Full story
  • Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform

    Jan 18, 2024, 08:49 AM by
    Innovative Technology Accurately Detects Cancer Based on Analysis of Changes to Protein Structure Novo Holdings led growth capital financing
    Full story
  • Alfa Chemistry Introduces Bio-based Polymers, Responding to Market Demand

    Jan 18, 2024, 08:49 AM by
    Full story
  • Alfa Chemistry Integrates Its Supply of Dietary Supplement Ingredients

    Jan 18, 2024, 08:49 AM by
    Full story
  • CD Formulation Excels in Developing and Optimizing Micro-Reservoir Controlled-Release Drug Delivery Systems

    Jan 18, 2024, 08:49 AM by
    Full story
  • Research Suggests New Immunopreventive Approach To Tackling Cancer

    Jan 18, 2024, 01:00 AM by User Not Found
    Bio-IT World | The lifetime probability of being diagnosed with an invasive cancer is estimated to be roughly 40% for both men and women, and there’s a strong possibility that they are all, in some sense, preventable. Scientific evidence suggests that the body’s immune system copes with the “internal danger” of tumor development the same way it deals with the external threat of infectious diseases.
    Full story
  • BioIVT Fuels Future Cell and Gene Therapy Breakthroughs at Advanced Therapies Week

    Jan 17, 2024, 08:41 AM by
    BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, will exhibit its latest Cell and Gene Therapy (CGT) innovations at Advanced Therapies Week, taking place at the Miami Beach Convention Center from January 16-19.
    Full story
  • PharmAlliance Announces Acquisition of Monitor for Hire

    Jan 17, 2024, 08:41 AM by
    Diversified pharmaceutical and life sciences services provider PharmAlliance has acquired Monitorforhire (MFH), the leading web-enabled resource management company connecting professionals with high-impact clinical research opportunities. Operating under BioBridges, PharmAlliance’s talent arm, this acquisition will introduce a new vertical, providing expertise and services to clients and its global network of 4k+ clinical research professionals. Key outcomes include: Bridging Talent Gaps Enhancing Efficiency and Efficacy Strengthening Collaborative Models
    Full story
  • Biopharma PEG Unveils Expanded Azide PEG Series

    Jan 17, 2024, 08:41 AM by
    Biopharma PEG, a leading provider of polyethylene glycol (PEG) derivatives, is proud to introduce an extended Azide PEG series that includes monodispersed, polydispersed, and multi-arm PEGs.
    Full story
  • «
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy